Balchem Corporation declined 1.56% in premarket trading. The company reported its Q1 2025 earnings, detailing its performance across segments such as Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The earnings call and related news events did not provide clear positive or negative catalysts for the stock's movement.
Comments
No comments yet